Log in to save to my catalogue

Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent...

Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1007_s00726_001_0106_6

Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent veratridine-induced neurotoxicity

About this item

Full title

Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent veratridine-induced neurotoxicity

Publisher

Austria

Journal title

Amino acids, 2002-01, Vol.23 (1-3), p.31-36

Language

English

Formats

Publication information

Publisher

Austria

More information

Scope and Contents

Contents

Nefopam hyghochloride is a potent analgesic compound commercialized in most Western Europe for 20 years, which possesses a profile distinct from that of opioids or anti-inflammatory drugs. Previous evidence suggested a central action of nefopam but the detailed mechanisms remain unclear. While, nefopam structure resembles that of orphenadrine, an u...

Alternative Titles

Full title

Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent veratridine-induced neurotoxicity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1007_s00726_001_0106_6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1007_s00726_001_0106_6

Other Identifiers

ISSN

0939-4451

E-ISSN

1438-2199

DOI

10.1007/s00726-001-0106-6

How to access this item